146 related articles for article (PubMed ID: 31375103)
21. De novo microdeletion of 5q14.3 excluding MEF2C in a patient with infantile spasms, microcephaly, and agenesis of the corpus callosum.
Shimojima K; Okumura A; Mori H; Abe S; Ikeno M; Shimizu T; Yamamoto T
Am J Med Genet A; 2012 Sep; 158A(9):2272-6. PubMed ID: 22848023
[TBL] [Abstract][Full Text] [Related]
22. An intellectually disabled patient with the 5q14.3q15 microdeletion syndrome associated with an apparently de novo t(2;5)(q13;q14).
Toral-López J; Buentello-Volante B; Balderas-Minor MM; Amezcua-Herrera C; Valdes-Miranda JM; González-Huerta LM; Gudiño M; Cuevas-Covarrubias SA; Zenteno JC
Am J Med Genet A; 2012 Apr; 158A(4):942-6. PubMed ID: 22419405
[No Abstract] [Full Text] [Related]
23. Whole genome paired-end sequencing elucidates functional and phenotypic consequences of balanced chromosomal rearrangement in patients with developmental disorders.
Schluth-Bolard C; Diguet F; Chatron N; Rollat-Farnier PA; Bardel C; Afenjar A; Amblard F; Amiel J; Blesson S; Callier P; Capri Y; Collignon P; Cordier MP; Coubes C; Demeer B; Chaussenot A; Demurger F; Devillard F; Doco-Fenzy M; Dupont C; Dupont JM; Dupuis-Girod S; Faivre L; Gilbert-Dussardier B; Guerrot AM; Houlier M; Isidor B; Jaillard S; Joly-Hélas G; Kremer V; Lacombe D; Le Caignec C; Lebbar A; Lebrun M; Lesca G; Lespinasse J; Levy J; Malan V; Mathieu-Dramard M; Masson J; Masurel-Paulet A; Mignot C; Missirian C; Morice-Picard F; Moutton S; Nadeau G; Pebrel-Richard C; Odent S; Paquis-Flucklinger V; Pasquier L; Philip N; Plutino M; Pons L; Portnoï MF; Prieur F; Puechberty J; Putoux A; Rio M; Rooryck-Thambo C; Rossi M; Sarret C; Satre V; Siffroi JP; Till M; Touraine R; Toutain A; Toutain J; Valence S; Verloes A; Whalen S; Edery P; Tabet AC; Sanlaville D
J Med Genet; 2019 Aug; 56(8):526-535. PubMed ID: 30923172
[TBL] [Abstract][Full Text] [Related]
24. 5q14.3 deletion neurocutaneous syndrome: Contiguous gene syndrome caused by simultaneous deletion of RASA1 and MEF2C: A progressive disease.
Ilari R; Agosta G; Bacino C
Am J Med Genet A; 2016 Mar; 170(3):688-93. PubMed ID: 26774077
[TBL] [Abstract][Full Text] [Related]
25. A de novo microdeletion of SEMA5A in a boy with autism spectrum disorder and intellectual disability.
Mosca-Boidron AL; Gueneau L; Huguet G; Goldenberg A; Henry C; Gigot N; Pallesi-Pocachard E; Falace A; Duplomb L; Thevenon J; Duffourd Y; St-Onge J; Chambon P; Rivière JB; Thauvin-Robinet C; Callier P; Marle N; Payet M; Ragon C; Goubran Botros H; Buratti J; Calderari S; Dumas G; Delorme R; Lagarde N; Pinoit JM; Rosier A; Masurel-Paulet A; Cardoso C; Mugneret F; Saugier-Veber P; Campion D; Faivre L; Bourgeron T
Eur J Hum Genet; 2016 Jun; 24(6):838-43. PubMed ID: 26395558
[TBL] [Abstract][Full Text] [Related]
26. A 5q12.1-5q12.3 microdeletion in a case with a balanced exceptional complex chromosomal rearrangement.
Cetin Z; Yakut S; Clark OA; Mihci E; Berker S; Luleci G
Gene; 2013 Mar; 516(1):176-80. PubMed ID: 23262338
[TBL] [Abstract][Full Text] [Related]
27. Identification of a 650 kb duplication at the X chromosome breakpoint in a patient with 46,X,t(X;8)(q28;q12) and non-syndromic mental retardation.
Cox JJ; Holden ST; Dee S; Burbridge JI; Raymond FL
J Med Genet; 2003 Mar; 40(3):169-74. PubMed ID: 12624134
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional and functional consequences of alterations to MEF2C and its topological organization in neuronal models.
Mohajeri K; Yadav R; D'haene E; Boone PM; Erdin S; Gao D; Moyses-Oliveira M; Bhavsar R; Currall BB; O'Keefe K; Burt ND; Lowther C; Lucente D; Salani M; Larson M; Redin C; Dudchenko O; Aiden EL; Menten B; Tai DJC; Gusella JF; Vergult S; Talkowski ME
Am J Hum Genet; 2022 Nov; 109(11):2049-2067. PubMed ID: 36283406
[TBL] [Abstract][Full Text] [Related]
29. Balanced translocation t(3;18)(p13;q22.3) and points mutation in the ZNF407 gene detected in patients with both moderate non-syndromic intellectual disability and autism.
Ren CM; Liang Y; Wei F; Zhang YN; Zhong SQ; Gu H; Dong XS; Huang YY; Ke H; Son XM; Tang D; Chen Z
Biochim Biophys Acta; 2013 Mar; 1832(3):431-8. PubMed ID: 23195952
[TBL] [Abstract][Full Text] [Related]
30. Microduplications of 3p26.3p26.2 containing CRBN gene in patients with intellectual disability and behavior abnormalities.
Papuc SM; Hackmann K; Andrieux J; Vincent-Delorme C; Budişteanu M; Arghir A; Schrock E; Ţuţulan-Cuniţă AC; Di Donato N
Eur J Med Genet; 2015 May; 58(5):319-23. PubMed ID: 25858704
[TBL] [Abstract][Full Text] [Related]
31. Position effect, cryptic complexity, and direct gene disruption as disease mechanisms in de novo apparently balanced translocation cases.
Aristidou C; Theodosiou A; Bak M; Mehrjouy MM; Constantinou E; Alexandrou A; Papaevripidou I; Christophidou-Anastasiadou V; Skordis N; Kitsiou-Tzeli S; Tommerup N; Sismani C
PLoS One; 2018; 13(10):e0205298. PubMed ID: 30289920
[TBL] [Abstract][Full Text] [Related]
32. Precise definition of the breakpoints of an apparently balanced translocation between chromosome 3q26 and chromosome 7q36: Role of KMT2C disruption.
Yamada M; Suzuki H; Miya F; Kosugiyama K; Ujiie T; Tonoki H; Kosaki K
Congenit Anom (Kyoto); 2023 Jul; 63(4):121-124. PubMed ID: 36946065
[TBL] [Abstract][Full Text] [Related]
33. [Cytogenetic-molecular analysis of balanced chromosomal rearrangements in nine patients with intellectual disability, dysmorphic features and congenital abnormalities].
Borg K; Bocian E; Stankiewicz P; Obersztyn E; Kruczek A; Nowakowska B; Ilnicka A; Mazurczak T
Med Wieku Rozwoj; 2006; 10(1 Pt 2):227-46. PubMed ID: 17028391
[TBL] [Abstract][Full Text] [Related]
34. Breakpoint analysis for cytogenetically balanced translocation revealed unexpected complex structural abnormalities and suggested the position effect for MEF2C.
Tamura T; Shimojima Yamamoto K; Imaizumi T; Yamamoto H; Miyamoto Y; Yagasaki H; Morioka I; Kanno H; Yamamoto T
Am J Med Genet A; 2023 Jun; 191(6):1632-1638. PubMed ID: 36916329
[TBL] [Abstract][Full Text] [Related]
35. Refining the phenotype associated with MEF2C point mutations.
Bienvenu T; Diebold B; Chelly J; Isidor B
Neurogenetics; 2013 Feb; 14(1):71-5. PubMed ID: 23001426
[TBL] [Abstract][Full Text] [Related]
36. [Familial presentation of microdeletion and inverted microduplication with array-CGH].
Beseler-Soto B; Jiménez-Candel MI; Pedrón-Marzal G; Pérez-García B; Carpena-Lucas PJ
Rev Neurol; 2014 Dec; 59(12):551-4. PubMed ID: 25501453
[TBL] [Abstract][Full Text] [Related]
37. The emerging microduplication 3q13.31: Expanding the genotype-phenotype correlations of the reciprocal microdeletion 3q13.31 syndrome.
Hervé B; Fauvert D; Dard R; Roume J; Cognard S; Goidin D; Lozach F; Molina-Gomes D; Vialard F
Eur J Med Genet; 2016 Sep; 59(9):463-9. PubMed ID: 27568866
[TBL] [Abstract][Full Text] [Related]
38. De novo 3q/7q translocation and associated interstitial 7q35 deletion.
Fryns JP; Kleczkowska A; van den Berghe H
Clin Genet; 1988 Jan; 33(1):60-2. PubMed ID: 3342549
[TBL] [Abstract][Full Text] [Related]
39. MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines.
Nagel S; Meyer C; Quentmeier H; Kaufmann M; Drexler HG; MacLeod RA
Leukemia; 2008 Mar; 22(3):600-7. PubMed ID: 18079734
[TBL] [Abstract][Full Text] [Related]
40. Interstitial deletion 5q14.3q21.3 with MEF2C haploinsufficiency and mild phenotype: when more is less.
Tonk V; Kyhm JH; Gibson CE; Wilson GN
Am J Med Genet A; 2011 Jun; 155A(6):1437-41. PubMed ID: 21567930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
